May
Medicinal Chemistry
Medicinal Chemistry&
Drug Discovery Biology
Drug Discovery BiologyStrategy Meeting West Coast USA 2026
Hard Rock Hotel San DiegoWhat makes our strategy meetings unique?
Roundtable Discussions
Intimate discussions led by renowned industry experts. Have your voice heard and debate alongside like-minded life science executives.
Unrivalled Networking
With senior delegation from big pharma and innovative biotech from across the West Coast, you can network with peers from different locations, all in one place.
Personalised Agenda
Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.
Solutions to your Problems
We’ve partnered with the best solution providers to solve your biggest challenges. Engage in pre-arranged, private meetings to address your specific needs and find a tangible solution.
Industry Researched Topics
We guarantee our agenda is up-to-date and mission critical because its designed by you. We speak to our extended network of senior decision makers to ensure the most important topics are discussed.
Senior Decision Makers
The entire strategy meeting is specifically tailored to the needs and challenges of senior life science professionals. Discover how your peers are dealing with the same challenges as you.
Our Past Facilitators
Our panel of facilitators play a key role in shaping the agenda for the day. See who will be bringing their expertise to the table at Medicinal Chemistry Strategy Meeting.
Andrea Small-Howard
President GB Sciences
Bill Jackson, Ph.D
Founder & CEO Base Pair Biotechnologies, Inc.
Bishnu Nayak
Senior Director/Site Head Neologics Bio
Bruce Kovacs
Afecta Pharmaceuticals
Elliott J. Brecht
Director of Business Development SAI Life
Fernando Aleman
Founder and CSO Navega Therapeutics
Igor O. Nasonkin
CEO Phythera Therapeutics
Jian Zuo
Co-founder and CEO Ting Therapeutics
Klaus Simonsen
Vice President, Head of External Research & Innovation Lundbeck
Mehran Moghaddam
CEO OROX Biosciences, Inc.
Moorthy Palanki
Program Director / Professor, Biotechnology California State University San Marcos
Sang Van
CEO Paramita Therapeutics, Inc.
Sudar Alagarsamy
Executive Director Program Management Arrowhead Pharmaceuticals
Tal Teitz
Co-founder Ting Therapeutics
Yoshi Satoh
Vice President of Chemistry Rev Therapeutics
Zev Wisotsky
Director, Drug Discovery New Modality Solutions Revvity Signals
Zhiyong Wang
Founder and Chief Scientific Officer Venquis TherapeuticsOUR PAST AGENDA
See Which Topics Are Up For Discussion
Roundtable Tracks
1Botanical Drug Discovery in the Age of AI: Bridging Natural Products and Predictive Models
-Andrea Small-Howard
President
GB Sciences
DMPK / ADME & Toxicology
Optimizing ADME: Bridging the Gap Between Drug Discovery and Clinical Success (Topic TBC)
-Igor Nasonkin
Co-founder & CEO
Phythera Therapeutics
Target Identification/ Lead Optimization
Maximizing Success in Drug Discovery with Early Translational Validation
-Bishnu Nayak
Senior Director/Site Head
Neologics Bio
Integrated Drug Discovery
From Hit to Lead: Accelerating Drug Discovery Through Cutting-Edge Chemistry and Innovative Screening Strategies (Topic TBC)
-Sudar Alagarsamy
Executive Director Program Management
Arrowhead Pharmaceuticals
Private Equity, Venture Capital & Strategic Partnerships
Collaborative Chemistry: The Business of Partnerships in Drug Innovation (Topic TBC)
-Klaus Simonsen
Vice President, Head of External Research & Innovation
Lundbeck
Roundtable Tracks
2Chemoproteomics: Probing Small Molecules’ Interactions with Complex Biological Systems (Topic TBC)
-Zev Wisotsky
Director, Drug Discovery New Modality Solutions
Revvity Signals
REVVITY SIGNALS
DMPK / ADME & ToxicologyAlternative (non-antibody-based) affinity reagents in therapeutic development
-Bill Jackson, Ph.D
Founder & CEO
Base Pair Biotechnologies, Inc.
SAI LIFE SCIENCES SPONSOR MEDICINAL CHEMISTRY & DRUG DISCOVERY BIOLOGY Monday, 10th November 2025 Hard Rock Hotel San Diego Agenda at a Glance STRATEGY MEETING WEST COAST USA 2025 BASEPAIR
Target Identification/ Lead OptimizationFragment Based Drug Discovery in the Spotlight: Emerging Trends in Hit Identification and Lead Optimization
Sponsor
Integrated Drug DiscoveryPredictive ADME-Tox in Leaner Times: Accelerating Risk Assessment Under Resource Constraints
-Elliott J. Brecht
Director of Business Development
SAI Life
SAI LIFE SCIENCES
Private Equity, Venture Capital & Strategic PartnershipsHow Strategic Partnerships Revolutionize Pharma R&D
Sponsor
Roundtable Tracks
3Emerging “Undruggable” Targets in Targeted Protein Degradation (Topic TBC)
-Zhiyong Wang
Founder and Chief Scientific Officer
Venquis Therapeutics
DMPK / ADME & Toxicology
Integrating Computational DMPK Tools for Faster and More Accurate Drug Profiling (Topic TBC)
-Mehran Moghaddam
CEO
OROX Biosciences, Inc.
Target Identification/ Lead Optimization
Protein vs RNA vs DNA targeting
-Fernando Aleman
Founder and CSO
Navega Therapeutics
Integrated Drug Discovery
Transforming RNA Biology into Drug Discovery with AI: From Complex Datasets to Targetable Insights
-Moorthy Palanki
Program Director / Professor, Biotechnology
California State University San Marcos
Private Equity, Venture Capital & Strategic Partnerships
Strategic Alliances and Investment Strategies: Fueling the Future of Drug Discovery
-Bruce Kovacs
Afecta Pharmaceuticals
Roundtable Tracks
4Explainable AI (XAI) and ML/AL as assistive intelligence to support rational lead optimization of small molecules
DMPK / ADME & Toxicology
Overcoming ADME Challenges in Small Molecule and Biologic Drug Discovery
Target Identification/ Lead Optimization
AI-Driven Drug Discovery: Transforming Hit Identification and Lead Optimization
-Yoshi Satoh
Vice President of Chemistry
Rev Therapeutics
Integrated Drug Discovery
Redefining Drug Discovery Through Molecular Multivalency: Engineering Dual-Function Therapeutics and Vaccines to Bridge Molecular Architecture, Precision Immuno-Oncology, and Infectious Disease
Private Equity, Venture Capital & Strategic Partnerships
Strategic Alliances and Investment Strategies: Fueling the Future of Drug Discovery
-Mehran Moghaddam
CEO
OROX Biosciences, Inc.
Aligning Capital, Capability, and Curiosity: The Future of Venture and Partnership in Drug Discovery
Reasons To Attend Our Strategy Meetings
Fully Interactive Format
There’s only so much you can learn from presentations and lectures. Instead, our interactive Roundtable Discussions let you debate the topics that really matter.
Senior Decision Makers
All our Strategy Meetings are aimed at director-level and above. Discover how your peers are tackling the industries biggest challenges and have your thoughts heard.
Personalised Agendas
Pick the roundtable discussions that you want to be part of. Simply choose your sessions and we’ll create a personalised agenda just for you.
Private and Intimate Networking
Small group discussions, private meetings, networking drink – however you choose to make those important connections, our Strategy Meetings have the solution.
Our Past Sponsors
Co-Host Sponsors
Partnering Sponsors
Key Opinion Leader
Media Partners
Explore Highlight From The Past Events
Gain valuable insights, discover innovative solutions and connect with industry leaders through snapshots of our most successful gatherings.
Watch to hear what your colleagues had to say…
Hotel & Venue
Hard Rock Hotel San Diego
You’re the main act in San Diego. At Hard Rock Hotel, we immerse you in our musical amenities, world-class service, and intoxicating location in downtown San Diego. Tour the Gaslamp Quarter on an Electra bike and walk a block to Petco Park.
Hotel Details Map & Directions Parking
Here To Help
Want to know more? Interested in sponsoring the event? Need help registering your team? Just get in touch and a member of the team will be happy to help.
Payment Securely powered by stripe
